Predictors of silent myocardial ischemia in resistant hypertensive patients

American Journal of Hypertension

Volumn 28, Issue 2, 2015, Pages 200-207

  Modolo, Rodrigo ^a   De Faria, Ana Paula ^a   Paganelli, Maria O ^a   Sabbatini, Andréa R ^a   Barbaro, Natália R ^a   Nascimento, Beatriz B ^a   Ramos, Celso D ^a   Fontana, Vanessa ^a   Calhoun, David A ^b   Moreno, Heitor ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Blood pressure; Coronary artery disease; Hypertension; Myocardial ischemia; Resistant hypertension; Target organ damage

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; VASODILATOR AGENT; ANTIHYPERTENSIVE AGENT;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; FLOW MEDIATED DILATION; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MYOCARDIAL PERFUSION IMAGING; OBESITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; SILENT MYOCARDIAL ISCHEMIA; STRESS MYOCARDIAL PERFUSION SCINTIGRAPHY; VASODILATATION; AGED; ALBUMINURIA; ASYMPTOMATIC DISEASE; BLOOD PRESSURE; BRACHIAL ARTERY; DIAGNOSTIC USE; ECHOGRAPHY; HEART VENTRICLE; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL; VASCULAR ENDOTHELIUM;

ADULT; AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; ASYMPTOMATIC DISEASES; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; BRACHIAL ARTERY; DIABETES MELLITUS; DIPYRIDAMOLE; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; MYOCARDIAL PERFUSION IMAGING; OBESITY; RISK FACTORS; VASODILATION; VASODILATOR AGENTS;

EID: 84922502748     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpu140     Document Type: Article

References (45)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged diferences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. Wong ND, Lopez VA, L'Italien G, Chen R, Kline SE, Franklin SS. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004. Arch Intern Med 2007; 167:2431-2436.
3. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Diferential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594-599.
4. Calhoun DA, Jones D, Textor S, Gof DC, Murphy T P, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientifc statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
5. Martins LC, Figueiredo VN, Quinaglia T, Boer-Martins L, Yugar-Toledo JC, Martin JFV, Demacq C, Pimenta E, Calhoun DA, Moreno H. Characteristics of resistant hypertension: ageing, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stifness. J Hum Hypertens 2011; 25:532-538.
6. Figueiredo VN, Yugar-Toledo JC, Martins LC, Martins LB, de Faria AP, de Haro Moraes C, Sierra C, Coca A, Moreno H. Vascular stifness and endothelial dysfunction: correlations at diferent levels of blood pressure. Blood Pressure 2012; 21:31-38.
7. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Manente BM, Cuccurullo F, Mezzetti A. Cardiovascular outcome in treated hypertensive patients with true and false responder hypertension. Am J Hypertens 2005; 18:42a-42a.
8. Muiesan ML, Salvetti M, Zulli R, Pasini G, Bettoni G, Monteduro C, Rizzoni D, Castellano M, Agabiti-Rosei E. Structural association between the carotid artery and the lef ventricle in a general population in Northern Italy: the Vobarno study. J Hypertens 1998; 16:1805-1812.
9. Elhendy A, Schinkel AFL, van Domburg RT, Bax JJ, Poldermans D. Prediction of cardiac death in hypertensive patients with suspected or known coronary artery disease by stress technetium-99m tetrofosmin myocardial perfusion. J Hypertens 2003; 21:1945-1951.
10. Lacourciere Y, Cote C, Lefebvre J, Poirier L, Dumont M. Identifying which treated hypertensive patients without known coronary artery disease should be tested for the presence of myocardial ischemia by perfusion imaging. J Clin Hypertens (Greenwich) 2007; 9:921-928.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
12. Matsui D, Hermann C, Klein J, Berkovitch M, Olivieri N, Koren G. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. J Clin Pharmacol 1994; 34:944-949.
13. de Souza WA, Sabha M, de Faveri Favero F, Bergsten-Mendes G, Yugar-Toledo JC, Moreno H. Intensive monitoring of adherence to treatment helps to identify "true" resistant hypertension. J Clin Hypertens (Greenwich) 2009; 11:183-191.
14. Morisky DE, Green LW, Levine DM. Concurrent and predictive-validity of a self-reported measure of medication adherence. Med Care 1986; 24:67-74.
15. Drager LF, Genta PR, Pedrosa R P, Nerbass FB, Gonzaga CC, Krieger EM, Lorenzi-Filho G. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010; 105:1135-1139.
16. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS, Myoca AHAWG. Standardized myocardial segmentation and nomenclature for tomo-graphic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002; 9:240-245.
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ, Prog NHBPE. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
18. Groppelli A, Omboni S, Parati G, Mancia G. Evaluation of noninva-sive blood pressure monitoring devices Spacelabs 90202 and 90207 versus resting and ambulatory 24-hour intra-arterial blood pressure. Hypertension 1992; 20:227-232.
19. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfeld J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. Guidelines for the ultrasound assessment of endothelial-dependent fow-mediated vasodilation of the brachial artery-a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-265.
20. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfeld JE. Noninvasive detection of endothe-lial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-1115.
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Grp CQW. Recommendations for chamber quantifcation: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantifcation writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiog 2005; 18:1440-1463.
22. Khouri SJ, Maly GT, Suh DD, Walsh TE. A practical approach to the echocardiographic evaluation of diastolic function. J Am Soc Echocardiog 2004; 17:290-297.
23. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk-factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-444.
24. Hage FG, Lusa L, Dondi M, Giubbini R, Iskandrian AE. Exercise stress tests for detecting myocardial ischemia in asymptomatic patients with diabetes mellitus. Am J Cardiol 2013; 112:14-20.
25. Lubaszewski W, Kawecka-Jaszcz K, Czarnecka D, Rajzer M, Stochmal A. Silent myocardial ischaemia in patients with essential arterial hypertension and non-insulin dependent diabetes mellitus. J Hum Hypertens 1999; 13:309-313.
26. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfeld JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994; 24:1468-1474.
27. Koyoshi R, Miura S, Kumagai N, Shiga Y, Mitsutake R, Saku K. Clinical signifcance of fow-mediated dilation, brachial intima-media thickness and pulse wave velocity in patients with and without coronary artery disease. Circ J 2012; 76:1469-1475.
28. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V, Severgnini B, Meani S, Magrini F, Zanchetti A. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001; 19:2063-2070.
29. Vernooij JWP, van der Graaf Y, Nathoe HM, Bemelmans RHH, Visseren FLJ, Spiering W. Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease. J Hypertens 2013; 31:492-500.
30. Salles GF, Cardoso CRL, Pereira VS, Fiszman R, Muxfeldt ES. Prognostic signifcance of a reduced glomerular fltration rate and interaction with microalbuminuria in resistant hypertension: a cohort study. J Hypertens 2011; 29:2014-2023.
31. Deckert T, Feldtrasmussen B, Borchjohnsen K, Jensen T, Kofoedenevoldsen A. Albuminuria refects widespread vascular dam-age-the steno hypothesis. Diabetologia 1989; 32:219-226.
32. Gillman M W, Kannel WB, Belanger A, Dagostino RB. Infuence of heart-rate on mortality among persons with hypertension-the Framingham study. Am Heart J 1993; 125:1148-1154.
33. Acelajado MC, Pisoni R, Dudenbostel T, Dell'Italia LJ, Cartmill F, Zhang B, Cofeld SS, Oparil S, Calhoun DA. Refractory hypertension: defnition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich) 2012; 14:7-12.
34. Boer-Martins L, Figueiredo VN, Demacq C, Martins LC, Consolin-Colombo F, Figueiredo MJ, Cannavan FPS, Moreno H. Relationship of autonomic imbalance and circadian disruption with obesity and type 2 diabetes in resistant hypertensive patients. Cardiovasc Diabetol 2011; 10:24-35.
35. Mansour P, Bostrom PA, Mattiasson I, Lilja B, Berglund G. Low blood-pressure levels and signs of myocardial-ischemia-importance of lef-ventricular hypertrophy. J Hum Hypertens 1993; 7:13-18.
36. Tsang TSM, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Lef atrial volume as a morphophysiologic expression of lef ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 2002; 90:1284-1289.
37. Fovino LN, Saladini G, Saladini F, Razzolini R, Evangelista L. Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10 year follow-up analysis. Eur J Nucl Med Mol I 2012; 39:S167-S167.
38. Elhendy A, van Domburg RT, Sozzi FB, Poldermans D, Bax JJ, Roelandt JRTC. Impact of hypertension on the accuracy of exercise stress myo-cardial perfusion imaging for the diagnosis of coronary artery disease. Heart 2001; 85:655-661.
39. Demir H, Tan YZ, Isgoren S, Gorur GD, Kozdag G, Ural E, Berk F. Comparison of exercise and pharmacological stress gated SPECT in detecting transient lef ventricular dysfunction. Ann Nucl Med 2008; 22:403-409.
40. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, Kelion AD, Al-Mohammad A, Prvulovich EM, Shaw LJ, Tweddel AC. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004; 31:261-291.
41. Gargiulo P, Petretta M, Bruzzese D, Cuocolo A, Prastaro M, D'Amore C, Vassallo E, Savarese G, Marciano C, Paolillo S, Filardi P P. Myocardial perfusion scintigraphy and echocardiography for detecting coronary artery disease in hypertensivepatients: a meta-analysis. Eur J Nucl Med Mol Imaging 2011; 38:2040-2049.
42. Allman KG, Muir A, Howell SJ, Hemming AE, Sear J W, Foex P. Resistant Hypertension and Preoperative Silent-Myocardial-Ischemia in Surgical Patients. Brit J Anaesth 1994; 73:574-578.
43. Bianchi S, Bigazzi R, Amoroso A, Campese VM. Silent ischemia is more prevalent among hypertensive patients with microalbuminuria and salt sensitivity. J Hum Hypertens 2003; 17:13-20.
44. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GBJ, Weintraub WS, Boden W, O'Rourke R, Teo K, Hartigan P, Weintraub W, Maron D, Mancini J, Weintraub W, Boden W, O'Rourke R, Teo K, Hartigan P, Knudtson M, Maron D, Bates E, Blaustein A, Booth D, Carere R, Ellis S, Gosselin G, Gau G, Jacobs A, King S, Kostuk W, Harris C, Spertus J, Peduzzi P, Ryan T, Turnbull B, Feldman T, Bonow R, Haskell W, Diehr P, Lachenbruch P, Waters D, Johnstone D, Cohen L, Cantin B, Hager W, Samaha F, Januzzi J, Arrighi J, Chaitman B, Weintraub W, Hartigan P, O'Rourke R, Boden W, Barnett P, Spertus J, Goeree R, Maron D, Boden W, O'Rourke R, Teo K, Weintraub W, Peduzzi P, Antonelli M, Smith J, Kilstrom R, Hunter B, O'Neil S, Economou T, Nabors J, Kossack A, Sather M, Harris C, Gagne W, Fye C, Marottoli R, Allore H, Beckwith D, Farrell W, Feldman R, Mehta R, Neiderman J, Perry E, Kasl S, Zeman M, O'Leary T, Huang G, Boden W, Dada M, Potter K, Rivera T, O'Rourke R, Casperson P, O'Shea A, Teo K, Woodcock G, Weintraub W, Barnett P, Goeree R, O'Brien B, Mancini GBJ, Yeoh E, Ladenson J, Tompson V, Chaitman B, Bertran T, Berman D, Gerlach J, Littman R, Shaw L, Calfas K, Sallis J, O'Rourke R, Baker P, Bolton J, Blaustein A, Rowe C, Morris K, Hofman S, Sedlis S, Keary M, Duvernoy C, Majors C, Shockey M, Zoble R, Fernandez I, Lehmann K, Sorley A, Abel M, Sheldon M, Wagoner K, Murphy E, Avalos K, Rossen J, Schneider K, Molavi B, Garza L, Barton P, Mavromatis K, Forghani Z, Smith R, Mitchell C, Ramanathan K, Touchstone T, Kostuk W, Sridhar K, Carr S, Wiseman D, Nawaz S, Dion C, Gosselin G, Teberge J, Cuso M, Title L, Simon P, Carroll L, Courtney-Cox K, Cohen E, Hsu E, Dzavik V, Lan J, Knudtson M, Lundberg D, Natarajan M, Cappelli G, Kutryk M, DiMarco A, Strauss B, Fung A, Chow J, Marr D, Fitzgerald F, Carere R, Nacario T, Tymchak W, Harris L, Lazzam C, Carter A, Palisaitis D, Mercure C, Bell M, Peterson M, Vicari R, Carroll M, Bates E, Luciano A, Mahrer P, Reyes S, Saucedo J, Vanwieren D, O'Keefe J, Kennedy P, Jacobs A, Berger C, Mayo S, Miller J, Arnold T, Kiernan F, Murphy D, Kugelmass A, Pangilinan R, Schwartz R, Caufeld L, Hansen D, Mitchell C, Carhart R, Pennella A, Ellis S, Stevenson C, Krone R, Humphrey J, Appleton C, Wisbey J, Stillabower M, Davidson M, Mathien J, Grp CTR. Optimal medical therapy with or without PCI for stable coronary disease. New Engl J Med 2007; 356:1503-1516.
45. Aarnoudse WH, Botman KJ, Pijls NH. False-negative myocardial scin-tigraphy in balanced three-vessel disease, revealed by coronary pressure measurement. Int J Cardiovasc Intervent 2003; 5:67-71.